2025
|
Invention
|
Composition for prevention or treatment of alzheimer's disease. Provided is a novel means capable... |
2019
|
Invention
|
Plasmalogen-containing composition.
This invention provides a technique that is capable of stabl... |
|
Invention
|
Plasmalogen-containing composition. Provided is a technique that makes it possible to store plasm... |
|
Invention
|
Method for producing phospholipid concentrate. This invention provides a technique that is capabl... |
|
Invention
|
Phospholipid concentrate manufacturing method. This invention provides a technique that is capabl... |
|
Invention
|
Phospholipid concentrate manufacturing method. Provided is a method in which, when obtaining a ph... |
|
Invention
|
Method for producing phospholipid concentrate. Provided is a phospholipid concentrate production ... |
2011
|
Invention
|
Testing method for determining dementia using blood sample. The purpose of the present invention ... |
|
Invention
|
Drug against central nervous system inflammation.
An objective of the present invention is to pr... |
|
Invention
|
Drug against central nervous system inflammation. The purpose of the present invention is to prov... |
|
Invention
|
Anti-atopic dermatitis agent. Disclosed is an anti-atopic dermatitis agent which ameliorate and t... |
|
Invention
|
Cerebral nerve cell neogenesis agent. An objective of the present invention is to provide a new s... |
|
Invention
|
Cerebral nerve cell neogenesis agent. Disclosed are: a novel substance having a cerebral nerve ce... |
2010
|
Invention
|
Method for producing glucosylceramide-containing material. Disclosed is a method for easily and e... |
|
Invention
|
Anti-hyperglycemic and/or anti-hyperlipidemic agent comprising material containing avian skin-der... |
2009
|
Invention
|
Method for production of highly pure phospholipid, and highly pure sphingomyelin and plasmalogen-... |
2008
|
Invention
|
Process for producing sphingomyelin and plasmalogen-form glycerophospholipid. Disclosed is a proc... |